Jump to content

Other advances in LC (ASCO 2009)


Recommended Posts

Two studies showed that treatment with targeted therapy drugs (drugs that target the faulty genes and proteins that contribute to cancer growth) showed the growth and spread of advanced NSCLC. These studies onclude:

* Adding the drug erlotinib (TARCEVA) to the follow-up treatment with the drug bevacizumab (AVASTIN)

*Adding the drug vandetanib (Zactima) to standard chemotherapy with docetaxel (Taxotere)

Go to www.cancer.net/ascoannualmeetings for additional information on these studies

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.